VERTEX PHARMACEUTICALS INC - DEF 14A

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

April 4, 2024

Period of Report

May 15, 2023

Accession Number

0001308179-24-000452

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →